Download in electronic PDF format for $25



Search the Complete Journal Archives

Lapatinib Ditosylate 50-mg/mL Oral Suspension

Author(s):  Allen Loyd V Jr

Issue:  Nov/Dec 2016 - Volume 20, Number 6
View All Articles in Issue

Abstract:  A formulation for preparing Lapatinib Ditosylate 50-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, lapatinib, hazardous medication, cancer, antineoplastic agent, kinase inhibitor

Related Categories: CANCER AND AIDS, FORMULATIONS

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Veterinary Transdermal Medications: A to Z Davidson Gigi S Mar/Apr 2003 106 Buy
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr Jul/Aug 2001 310 Buy
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr Nov/Dec 2003 449-450 Buy
Imatinib 40-mg/mL Oral Suspension Allen Loyd V Jr Nov/Dec 2016 510 Buy
Lapatinib Ditosylate 50-mg/mL Oral Suspension Allen Loyd V Jr Nov/Dec 2016 511 Buy
Erlotinib 10-mg/mL Oral Suspension Allen Loyd V Jr Nov/Dec 2016 508 Buy
Sunitinib 10-mg/mL Oral Suspension Allen Loyd V Jr May/Jun 2010 248 Buy
Basics of Compounding for Cough Allen Loyd V Jr Nov/Dec 2004 462-465 Buy
Compounding for the Effects of Weapons of Mass Destruction Sammarco Domenic A Jan/Feb 2003 10 View Sample
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs Allen Loyd V Jr, Okeke Claudia C Jan/Feb 2009 56-62 Buy